nach oben

Erschienen in:

01.03.2012 | Original Article

Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study

verfasst von: Eunyoung Kang, Eun Joo Yang, Sun-Mi Kim, Il Yong Chung, Sang Ah Han, Do-Hoon Ku, Soek-Jin Nam, Jung-Hyun Yang, Sung-Won Kim

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The worldwide use of complementary and alternative medicine (CAM) among cancer patients has increased, with breast cancer patients being more likely to use CAM compared with any other cancer patients. However, few surveys have systematically described CAM use among Korean breast cancer patients. This study investigated the use of CAM among patients who were diagnosed with breast cancer, along with the relevant demographic and clinical factors related to CAM use. We also compared the difference in quality of life between CAM users and nonusers.

Methods

A total of 661 patients were invited to participate in this study during routine clinic visits, with 425 patients ultimately participating. Three hundred ninety-nine questionnaires were completed and used in the final analysis. Quality of life was evaluated based on the Korean versions of the EORTC QLQ-C30 and EORTC QLQ-BR23.

Results

Previous or current CAM usage was reported by 229 patients (57.4%). Independent factors related to CAM use were marital status, cancer stage, and coexisting illness. The common types of CAM use included exercise therapy (43.2%) and ingestion of vitamins and minerals (41.9%). The reasons for CAM use were to boost the immune system (53.2%), promote health (46.8%) and prevent recurrence (37.7%). Large proportions (70.4%) of CAM users did not discuss their CAM use with their physicians. Only a small number of CAM users (2.5%) answered that they were unsatisfied with their CAM use, with most CAM users reporting that they would continue their CAM use. Quality of life was not significantly different between CAM users and nonusers.

Conclusions

A significant number of patients with breast cancer have used CAM, and health care providers should be aware of the variety of CAM methods and their patients’ CAM uses for the proper management of breast cancer.

Nur mit Berechtigung zugänglich

Eisenberg DM, Davis RB, Ettner SL et al (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280(18):1569–1575PubMedCrossRef

Cassileth BR, Schraub S, Robinson E, Vickers A (2001) Alternative medicine use worldwide: the International Union Against Cancer survey. Cancer 91(7):1390–1393PubMedCrossRef

Lee SI, Khang YH, Lee MS, Koo HJ, Kang WC, Hong CG (1999) Complementary and alternative medicine use in Korea: prevalence, pattern of use, and out-of-pocket expenditures. Korean J Prev Med 32:546–555

Ock SM, Choi JY, Cha YS et al (2009) The use of complementary and alternative medicine in a general population in South Korea: results from a national survey in 2006. J Korean Med Sci 24(1):1–6PubMedCrossRef

Lee KS, Ahn HS, Hwang LI, Lee YS, Koo BH (1998) Utilization of alternative therapies in cancer patients. Cancer Res Treat 30:203–213

Kim MJ, Lee SD, Kim DR et al (2004) Use of complementary and alternative medicine among Korean cancer patients. Korean J Intern Med 19:250–256PubMed

Morris KT, Johnson N, Homer L, Walts D (2000) A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg 179(5):407–411PubMedCrossRef

Gray RE, Fitch M, Goel V, Franssen E, Labrecque M (2003) Utilization of complementary/alternative services by women with breast cancer. J Health Soc Policy 16(4):75–84PubMedCrossRef

Ashikaga T, Bosompra K, O’Brien P, Nelson L (2002) Use of complementary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 10:542–548PubMedCrossRef

10.

Boon H, Stewart M, Kennard MA et al (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18(13):2515–2521PubMed

11.

Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD (2006) Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study. Breast Cancer Res Treat 100(2):219–227PubMedCrossRef

12.

Nagel G, Hoyer H, Katenkamp D (2004) Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey. Support Care Cancer 12(11):789–796PubMedCrossRef

13.

Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83(4):777–782PubMedCrossRef

14.

Kristoffersen AE, Fonnebo V, Norheim AJ (2008) Use of complementary and alternative medicine among patients: classification criteria determine level of use. J Altern Complement Med 14(8):911–919PubMedCrossRef

15.

Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92(1):42–47PubMedCrossRef

16.

Cui Y, Shu XO, Gao Y et al (2004) Use of complementary and alternative medicine by chinese women with breast cancer. Breast Cancer Res Treat 85(3):263–270PubMedCrossRef

17.

Shen J, Andersen R, Albert PS et al (2002) Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med 2:8PubMedCrossRef

18.

Henderson JW, Donatelle RJ (2004) Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med 10(1):52–57PubMed

19.

Carlsson M, Arman M, Backman M, Flatters U, Hatschek T, Hamrin E (2004) Evaluation of quality of life/life satisfaction in women with breast cancer in complementary and conventional care. Acta Oncol 43(1):27–34PubMedCrossRef

20.

Carpenter CL, Ganz PA, Bernstein L (2009) Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat 116(2):387–396PubMedCrossRef

21.

Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340(22):1733–1739PubMedCrossRef

22.

Kronenberg F, Cushman LF, Wade CM, Kalmuss D, Chao MT (2006) Race/ethnicity and women’s use of complementary and alternative medicine in the United States: results of a national survey. Am J Public Health 96(7):1236–1242PubMedCrossRef

23.

Hong CD (2001) Complementary and alternative medicine in Korea: current status and future prospects. J Altern Complement Med 7(Suppl 1):S33–S40PubMedCrossRef

24.

Kim DY, Kim BS, Lee KH et al (2008) Discrepant views of Korean medical oncologists and cancer patients on complementary and alternative medicine. Cancer Res Treat 40(2):87–92PubMedCrossRef

25.

Adler SR, Fosket JR (1999) Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract 48(6):453–458PubMed

26.

Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328(4):246–252PubMedCrossRef

27.

Chung HJ, Kim MR, Bae JS et al (2006) Complementary and alternative medicine in patients with breast cancer. J Breast Cancer 9:361–366CrossRef

28.

Henderson JW, Donatelle RJ (2003) The relationship between cancer locus of control and complementary and alternative medicine use by women diagnosed with breast cancer. Psychooncology 12(1):59–67PubMedCrossRef

29.

Montazeri A, Sajadian A, Ebrahimi M, Akbari ME (2005) Depression and the use of complementary medicine among breast cancer patients. Support Care Cancer 13(5):339–342PubMedCrossRef

30.

Owens B, Jackson M, Berndt A (2009) Complementary therapy used by Hispanic women during treatment for breast cancer. J Holist Nurs 27(3):167–176PubMedCrossRef

31.

Gansler T, Kaw C, Crammer C, Smith T (2008) A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society’s studies of cancer survivors. Cancer 113(5):1048–1057PubMedCrossRef

32.

Greenlee H, Kwan ML, Ergas IJ et al (2009) Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat 117(3):653–665PubMedCrossRef

33.

Jordan ML, Delunas LR (2001) Quality of life and patterns of nontraditional therapy use by patients with cancer. Oncol Nurs Forum 28(7):1107–1113PubMed

34.

Kappauf H, Leykauf-Ammon D, Bruntsch U et al (2000) Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and haematology. Support Care Cancer 8(4):314–322PubMedCrossRef

35.

Paltiel O, Avitzour M, Peretz T et al (2001) Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 19(9):2439–2448PubMed

36.

Boon H, Brown J, Gavin A (2000) What are the experiences of women with breast cancer as they decide whether to use complementary/alternative medicine? West J Med 173(1):39PubMedCrossRef

37.

Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 89(4):873–880PubMedCrossRef

38.

Pedersen CG, Christensen S, Jensen AB, Zachariae R (2009) Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer. Eur J Cancer 45(18):3172–3181PubMedCrossRef

39.

Helyer LK, Chin S, Chui BK et al (2006) The use of complementary and alternative medicines among patients with locally advanced breast cancer—a descriptive study. BMC Cancer 6:39PubMedCrossRef

40.

Chen Z, Gu K, Zheng Y, Zheng W, Lu W, Shu XO (2008) The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med 14(8):1049–1055PubMedCrossRef

41.

Yap KP, McCready DR, Fyles A, Manchul L, Trudeau M, Narod S (2004) Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery. Breast J 10(6):481–486PubMedCrossRef

42.

Ashikaga T, Bosompra K, O’Brien P, Nelson L (2002) Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 10(7):542–548PubMedCrossRef

43.

Jacobson JS, Workman SB, Kronenberg F (2000) Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol 18(3):668–683PubMed

44.

Girgis A, Adams J, Sibbritt D (2005) The use of complementary and alternative therapies by patients with cancer. Oncol Res 15(5):281–289PubMed

45.

Montazeri A, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I (2007) Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. Eur J Cancer Care (Engl) 16(2):144–149CrossRef

46.

Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H (2002) Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives. Psychooncology 11(3):212–220PubMedCrossRef

47.

Schofield P, Diggens J, Charleson C, Marigliani R, Jefford M (2010) Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns 79(2):143–151PubMedCrossRef

Titel: Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study
verfasst von: Eunyoung Kang
Eun Joo Yang
Sun-Mi Kim
Il Yong Chung
Sang Ah Han
Do-Hoon Ku
Soek-Jin Nam
Jung-Hyun Yang
Sung-Won Kim
Publikationsdatum: 01.03.2012
Verlag: Springer-Verlag
Erschienen in: Supportive Care in Cancer / Ausgabe 3/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-011-1094-z

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma

Relationships between the characteristics of oncohematology services providing palliative care and the sociodemographic characteristics of caregivers using health indicators: social support, perceived stress, coping strategies, and quality of work life

Falls in persons with chemotherapy-induced peripheral neuropathy

Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy

Differential responses of fibroblasts, non-neoplastic epithelial cells, and oral carcinoma cells to low-level laser therapy

Variations in process and outcome in inpatient palliative care services in Korea

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie